Skip Navigation
Skip to contents



10 results

Identification of CLP36 as a Tumor Antigen that Induces an Antibody Response in Pancreatic Cancer

Hong SH

  • Cancer Res Treat.
  • 2005 Feb;37(1):71-77.
PURPOSE: Pancreatic cancer has a poor prognosis, due in part to the lack of an effective approach for its early detection. The identification of tumor antigens potentially provides a means...
Immunization with Adenoviral Vectors Carrying Recombinant IL-12 and E7 Enhanced the Antitumor Immunity against Human Papillomavirus 16-associated Tumor

Park EK, Kim YW, Lee JM, NamKoong S, Kim DG, Chun HJ, Han BD, Bae SM, Jin HS, Sin JI, Ahn WS

  • Cancer Res Treat.
  • 2005 Feb;37(1):63-70.
PURPOSE: Human papillomavirus (HPV) infection has a significant role in cervical carcinogenesis, and HPV oncoprotein E7 plays an important part in the formation and maintenance of cervical cancer. Interleukin-12 (IL-12)...
cDNA Microarray Analysis of Differential Gene Expression in Gastric Cancer Cells Sensitive and Resistant to 5-Fluorouracil and Cisplatin

Ahn MJ, Yoo YD, Lee KH, Ahn JI, Yu DH, Lee HS, Oh HS, Choi JH, Lee YS

  • Cancer Res Treat.
  • 2005 Feb;37(1):54-62.
PURPOSE: Gastric cancer is one of the most prevalent cancers worldwide. 5-fluorouracil (5-FU) and cisplatin are the most commonly used drugs for the treatment of gastric cancer. However, a significant...
Clinical Prognostic Factors for Radical Cystectomy in Bladder Cancer

Jeon SH, Jeon SH, Chang SG

  • Cancer Res Treat.
  • 2005 Feb;37(1):48-53.
PURPOSE: We investigated the effects of radical cystectomy and the prognostic factors that affect the survival of bladder cancer patients. MATERIALS AND METHODS: From 1979 to 2002, 59 patients with...
Comparison of 30 mg and 40 mg of Mitomycin C Intravesical Instillation in Korean Superficial Bladder Cancer Patients: Prospective, Randomized Study

Jeong CW, Jeon HG, Kwak C, Jeong H, Lee SE

  • Cancer Res Treat.
  • 2005 Feb;37(1):44-47.
PURPOSE: A prospective study was performed to compare the efficacy and safety of intravesical mitomycin C (MMC) instillation for the prophylaxis of bladder cancer at different concentrations (30 mg or...
A Preliminary Results of a Randomized Trial Comparing Monthly 5-flourouracil and Cisplatin to Weekly Cisplatin Alone Combined with Concurrent Radiotherapy for Locally Advanced Cervical Cancer

Kim YS, Shin SS, Choi EK, Kim JH, Ahn SD, Lee SW, Park HJ, Kim YT, Mok JE, Nam JH

  • Cancer Res Treat.
  • 2005 Feb;37(1):37-43.
PURPOSE: To determine the superior chemotherapeutic regimen between monthly 5-FU plus cisplatin (FP) and weekly cisplatin alone in concurrent chemoradiotherapy for locally advanced cervical cancer, the compliance of treatment, response,...
Treatment Outcome of Limited Stage Hodgkin's Disease

Kang JH, Ahn YC, Kim WS, Kang WK

  • Cancer Res Treat.
  • 2005 Feb;37(1):31-36.
PURPOSE: The 10-year overall survival rate following conventional treatments for patients with limited-stage Hodgkin's disease (HD) exceeds 90%. However, the clinical features and treatment outcome of HD in Korea have...
High-Dose Chemotherapy of Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) Followed by Autologous Stem-Cell Transplantation for Metastatic Breast Cancer Patients: A 6-Year Follow-Up Result

Sohn HJ, Kim SH, Lee GW, Kim S, Kang HJ, Ahn JH, Kim SB, Kim SW, Kim WK, Suh C

  • Cancer Res Treat.
  • 2005 Feb;37(1):24-30.
PURPOSE: The benefit of high-dose chemotherapy (HDC) for metastatic breast cancer (MBC) is controversial. We evaluated the efficacy and safety of HDC with cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by...
Single Immunochemical Fecal Occult Blood Test for Detection of Colorectal Neoplasia

Sohn DK, Jeong SY, Choi HS, Lim SB, Huh JM, Kim DH, Kim DY, Kim YH, Chang HJ, Jung KH, Ahn JB, Kim HK, Park JG

  • Cancer Res Treat.
  • 2005 Feb;37(1):20-23.
PURPOSE: This study was designed to investigate the validity of a single immunochemical fecal occult blood test (FOBT) for detection of colorectal neoplasia. MATERIALS AND METHODS: A total of 3,...
Biology of SNU Cell Lines

Ku JL, Park JG

  • Cancer Res Treat.
  • 2005 Feb;37(1):1-19.
SNU (Seoul National University) cell lines have been established from Korean cancer patients since 1982. Of these 109 cell lines have been characterized and reported, i.e., 17 colorectal carcinoma, 12...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: